Blueprint Medicines Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2025 to a ratio of 7.38, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Blueprint Medicines in Mar 31 2025 quarter, has decreased to 49 days, compared to 51 days, in the Dec 31 2024 quarter.

If we take a look into Healthcare sector 205 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1797, from overall ranking in the fourth quarter 2024 at 2118.

What is Receivable Turnover Ratio?
What is Blueprint Medicines Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BPMC Receivables Turnover Ratio	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Receivable Change	30.04 %	76.98 %	61.07 %	142.01 %	100.11 %
Y / Y Revenue Change	55.45 %	88.19 %	126.61 %	139.98 %	67.25 %
Receivable Turnover Ratio (TTM)	7.38	7.1	6.94	6.44	6.44
BPMC's Total Ranking	# 1797	# 2118	# 1827	# 1729	# 423
Accounts Receivable average collection period days	49	51	53	57	57
Seq. Receivable Change	3.02 %	15.17 %	-22.62 %	41.65 %	40.21 %
Seq. Revenue Change	2.08 %	14.19 %	-7.22 %	43.74 %	23.58 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 68
Healthcare Sector	# 206
Overall Market	# 1797

Receivable Turnover Ratio Statistics
High	Average	Low
92.28	13.53	-125.4
(Dec 31 2019)		(Jun 30 2019)

BPMC Company Profile • Back to BPMC Efficiency Comparisons • Compare BPMC Receivables Turnover Ratio to its Competitors

Financial Statements
Blueprint Medicines's Accounts Receivable	$ 78 Millions	Visit BPMC's Balance sheet
Blueprint Medicines's Sales TTM	$ 562 Millions	Visit BPMC's Income Statement
Sources of BPMC's Revenues		Visit BPMC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BPMC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BPMC's Growth Rates	BPMC's Roa	BPMC's Inventory Turnover Ratio	BPMC's Dividend Comparisons
BPMC's Profitability Ratios	BPMC's Roi	BPMC's Asset Turnover Ratio	BPMC's Dividend Growth
BPMC's Valuation Ratios	BPMC's Roe	BPMC's Financial Strength Ratios	BPMC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2025	Receivable at quarter ending Mar 31 2025
Ethema Health Corporation	19.45	$ 8.235 Millions	$ 0.423 Millions
Valion Bio Inc	19.29	$ 0.516 Millions	$ 0.027 Millions
Xoma Royalty Corporation	19.17	$ 42.909 Millions	$ 2.238 Millions
Neuroone Medical Technologies Corp	18.78	$ 6.864 Millions	$ 0.365 Millions
Novavax inc	17.94	$ 1,254.962 Millions	$ 69.966 Millions
Dr Reddy s Laboratories Limited	17.56	$ 3,811.000 Millions	$ 217.000 Millions
Talkspace Inc	17.56	$ 193.386 Millions	$ 11.012 Millions
Milestone Scientific Inc	17.43	$ 8.418 Millions	$ 0.483 Millions
Neuraxis Inc	17.06	$ 2.935 Millions	$ 0.172 Millions
Innovage Holding Corp	16.44	$ 831.684 Millions	$ 50.574 Millions
Silence Therapeutics Plc	16.07	$ 27.701 Millions	$ 1.724 Millions
Spero Therapeutics Inc	15.95	$ 44.584 Millions	$ 2.796 Millions
Generation Bio Co	15.93	$ 24.556 Millions	$ 1.541 Millions
Petvivo Holdings Inc	15.90	$ 1.133 Millions	$ 0.071 Millions
Ontrak Inc	15.28	$ 9.890 Millions	$ 0.647 Millions
Kiniksa Pharmaceuticals International Plc	15.14	$ 481.166 Millions	$ 31.782 Millions
Mannkind Corporation	14.48	$ 297.595 Millions	$ 20.559 Millions
Icu Medical Inc	14.25	$ 2,419.911 Millions	$ 169.876 Millions
Inmed Pharmaceuticals Inc	14.25	$ 4.515 Millions	$ 0.317 Millions
Co diagnostics Inc	14.01	$ 3.498 Millions	$ 0.250 Millions
Biofrontera Inc	13.45	$ 59.599 Millions	$ 4.431 Millions
China Pharma Holdings Inc	13.28	$ 4.295 Millions	$ 0.323 Millions
Newamsterdam Pharma Company N v	13.25	$ 47.140 Millions	$ 3.559 Millions
Grail Inc	13.17	$ 130.711 Millions	$ 9.925 Millions
Rosecliff Acquisition Corp I	13.04	$ 29.581 Millions	$ 2.268 Millions
Quipt Home Medical Corp	13.03	$ 425.431 Millions	$ 32.657 Millions
Day One Biopharmaceuticals Inc	13.02	$ 161.922 Millions	$ 12.440 Millions
Ptc Therapeutics inc	12.99	$ 1,772.758 Millions	$ 136.420 Millions
Voyager Therapeutics Inc	12.89	$ 66.958 Millions	$ 5.196 Millions
Qhslab Inc	12.70	$ 2.289 Millions	$ 0.180 Millions

Date modified: 2026-08-29T17:30:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.